Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Zataria multiflora** is a medicinal plant species used as a botanical therapeutic, typically as a plant extract or herbal preparation rather than a single defined small-molecule drug. It has been studied clinically in Iran for **ulcerative colitis** and **overweight/obesity-related metabolic endpoints**. Reported pharmacology for *Zataria multiflora* preparations includes **anti-inflammatory, antioxidant, and immunomodulatory activity**, with clinical and translational data suggesting downregulation of inflammatory pathways such as **NF-kappa B**, **IL-17**, and **IFN-gamma** signaling. The exact active constituents and primary molecular target are not fully standardized across preparations; published effects are generally attributed to phytochemical mixtures in the plant, including thymol- and carvacrol-containing extracts and related phenolic constituents. The asset is best characterized as a **botanical plant extract / herbal medicine** in exploratory clinical development rather than a standardized approved pharmaceutical product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zataria multiflora.